AFJK · Aimei Health Technology Co., Ltd.
$12.56
+0.23 (+1.87%)
At close · Aug 21
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that if we are unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of our IPO, the requirement that we cease all operations, redeem the public shares, and thereafter liquidate and dissolve, raises substantial doubt about the ability to continue as a going concern within one year after the date that the unaudited financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$39.77M
Shares
3.17M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel Veikko Polvi | director | Appointed | 2026-06-29 |
| Junheng Xie | director | Appointed | 2024-04-19 |
| Junheng Xie | Chief Executive Officer | Appointed | 2024-04-19 |
| Juan Fernandez Pascual | director | Resigned | 2024-04-19 |
| Juan Fernandez Pascual | Chief Executive Officer | Resigned | 2024-04-19 |
Key facts
CIK
1979005
CUSIP
G01341109
13F (30d)
20 filings
19 filers